Clinical Trial Update: The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

View source ↗

Summary

The Monument Test is introduced as a new assessment tool to evaluate the ability to name and identify unique entities in Alzheimer’s disease. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Alzheimer s Disease | Status: NOT_YET_RECRUITING